Medtronic PLC (MDT)
83.66
+0.09
(+0.11%)
USD |
NYSE |
Mar 18, 16:00
83.99
+0.33
(+0.39%)
After-Hours: 20:00
Medtronic Cash from Operations (TTM): 6.47B for Jan. 31, 2024
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
January 31, 2024 | 6.47B |
October 31, 2023 | 5.57B |
July 31, 2023 | 5.831B |
April 30, 2023 | 6.039B |
January 31, 2023 | 5.636B |
October 31, 2022 | 6.29B |
July 31, 2022 | 7.137B |
April 30, 2022 | 7.346B |
January 31, 2022 | 7.034B |
October 31, 2021 | 7.162B |
July 31, 2021 | 7.254B |
April 30, 2021 | 6.24B |
January 31, 2021 | 5.945B |
October 31, 2020 | 5.996B |
July 31, 2020 | 6.002B |
April 30, 2020 | 7.234B |
January 31, 2020 | 7.871B |
October 31, 2019 | 7.519B |
July 31, 2019 | 6.815B |
April 30, 2019 | 7.007B |
January 31, 2019 | 5.958B |
October 31, 2018 | 5.905B |
July 31, 2018 | 5.649B |
April 30, 2018 | 4.684B |
January 31, 2018 | 5.419B |
Date | Value |
---|---|
October 31, 2017 | 5.502B |
July 31, 2017 | 6.067B |
April 30, 2017 | 6.88B |
January 31, 2017 | 6.433B |
October 31, 2016 | 6.145B |
July 31, 2016 | 5.952B |
April 30, 2016 | 5.218B |
January 31, 2016 | 5.804B |
October 31, 2015 | 5.774B |
July 31, 2015 | 5.408B |
April 30, 2015 | 4.902B |
January 31, 2015 | 4.318B |
October 31, 2014 | 4.163B |
July 31, 2014 | 4.286B |
April 30, 2014 | 4.959B |
January 31, 2014 | 4.901B |
October 31, 2013 | 4.735B |
July 31, 2013 | 4.593B |
April 30, 2013 | 4.942B |
January 31, 2013 | 4.716B |
October 31, 2012 | 4.409B |
July 31, 2012 | 4.687B |
April 30, 2012 | 4.47B |
January 31, 2012 | 4.219B |
October 31, 2011 | 4.325B |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
5.57B
Minimum
Oct 2023
7.871B
Maximum
Jan 2020
6.620B
Average
6.642B
Median
Cash from Operations (TTM) Benchmarks
Boston Scientific Corp | 2.503B |
Stryker Corp | 3.711B |
Abbott Laboratories | 7.261B |
Axonics Inc | -2.016M |
Reshape Lifesciences Inc | -17.33M |